Literature DB >> 4918995

Phosphonomycin. 3. Evaluation in vitro.

D Hendlin, B M Frost, E Thiele, H Kropp, M E Valiant, B Pelak, B Weissberger, C Cornin, A K Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4918995

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  5 in total

1.  Enteropathogenic Esch. coli gastroenteritis in premature infants and children treated with fosfomycin.

Authors:  F Baquero; E Canedo; A RODRIGUEZ; E Jaso
Journal:  Arch Dis Child       Date:  1975-05       Impact factor: 3.791

2.  Antibacterial properties of alafosfalin combined with cephalexin.

Authors:  F R Atherton; M J Hall; C H Hassall; S W Holmes; R W Lambert; W J Lloyd; L J Nisbet; P S Ringrose; D Westmacott
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

3.  Microbial epoxidation of cis-propenylphosphonic to (-)-cis-1,2-epoxypropylphosphonic acid.

Authors:  R F White; J Birnbaum; R T Meyer; J ten Broeke; J M Chemerda; A L Demain
Journal:  Appl Microbiol       Date:  1971-07

4.  Fosfomycin trometamol: activity in vitro against urinary tract pathogens.

Authors:  D Greenwood
Journal:  Infection       Date:  1990       Impact factor: 3.553

5.  The renoprotective effect of concomitant fosfomycin in the treatment of pulmonary exacerbations in cystic fibrosis.

Authors:  Mohamed Al-Aloul; Dilip Nazareth; Martin Walshaw
Journal:  Clin Kidney J       Date:  2019-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.